Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms

[1]  S. Leucht,et al.  Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review. , 2012, Schizophrenia bulletin.

[2]  S. Dursun,et al.  Functional neuroimaging of minocycline's effect in a patient with schizophrenia , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  Y. Levkovitz,et al.  A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. , 2010, The Journal of clinical psychiatry.

[4]  S. Dursun,et al.  Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[5]  D. Goff.  Review: lamotrigine may be an effective treatment for clozapine resistant schizophrenia , 2009, Evidence-based mental health.

[6]  J. Tiihonen,et al.  The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis , 2009, Schizophrenia Research.

[7]  H. Manev,et al.  Minocycline, schizophrenia and GluR1 glutamate receptors , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  H. Yasuda,et al.  Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study , 2008, Clinical neuropharmacology.

[9]  W. Fu,et al.  Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus , 2008, Epilepsia.

[10]  Yuko Fujita,et al.  Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  E. Spina,et al.  The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: A double-blind, placebo-controlled study , 2007, Schizophrenia Research.

[12]  H. Yasuda,et al.  Possible antipsychotic effects of minocycline in patients with schizophrenia , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[13]  K. Hashimoto,et al.  Minocycline Attenuates Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Administration of the NMDA Receptor Antagonist Dizocilpine , 2007, Neuropsychopharmacology.